Visalytics
Visalytics
approved EB-2 (NIW)

Postdoctoral Associate

Neuroscience · Taiwan · 2023-01-19

Processing Time
90 days
Decision Date
2023-01-19
Location
Connecticut
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research on developing novel therapies for neurodegenerative diseases by employing advanced electrophysiological and genetic manipulation techniques. Her work focuses on uncovering neurodegenerative mechanisms to improve therapeutic outcomes for conditions such as Huntington’s, Alzheimer’s, and Parkinson’s disease.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses neurodegenerative diseases affecting millions of Americans and carries significant economic implications for U.S. healthcare costs.

2 Well-positioned to Advance the Endeavor Met

The petitioner has 7 years of experience in electrophysiology and genetic engineering, supported by a record of 9 publications and 108 citations.

3 Waiver Benefit Met

On balance, the petitioner’s contributions to mitigating illnesses like Alzheimer's justify a waiver of the job offer requirement for the benefit of national health.

Why This Petition Was Approved

The petition was approved based on the petitioner's 9 peer-reviewed journal articles (3 first-authored) and 108 citations, demonstrating significant field impact. Evidence included 4 expert recommendation letters, 7 years of specialized experience in genetic engineering, and proof of research funding from the National Institutes of Health (NIH).

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Government Alignment

Similar Cases

Scientist

Biotechnology · India

WeGreened EB-2 (NIW) approved
New York 106 days 2023-01-28
The petitioner proposes to elucidate the genetic mechanisms underlying neurodegenerative diseases using expertise in biochemistry, genetics, and molecular biology. The work focuses on identifying new biological targets for the treatment of Alzheimer’s disease, Parkinson’s disease, and other dementias to provide insights into neuronal degeneration.
View Case

Doctor

Biotechnology · China

WeGreened EB-2 (NIW) rfe approved
484 days 2025-10-31
The petitioner proposes to continue critical research using cellular and molecular techniques to elucidate the mechanisms of neurodegenerative diseases. This work aims to facilitate the development of new and improved prognostic and diagnostic tools for medical applications.
View Case

Research Scientist

Biotechnology · South Korea

WeGreened EB-2 (NIW) approved
Massachusetts 5 days 2024-01-30
The petitioner proposes to continue her research elucidating the role of innate immune signaling and cell-type-specific pathway regulation in neurodegenerative diseases. Her work focuses on developing next-generation diagnostics and therapeutics to improve treatment interventions and reduce side effects for patients with neurological disorders.
View Case

Scientist

Research and Development · China

WeGreened EB-2 (NIW) approved
California 474 days 2025-03-07
The petitioner proposes to continue research into the cellular and molecular mechanisms of learning and memory to identify new therapeutic targets for neurodegenerative conditions like Alzheimer’s and Parkinson’s disease. The work involves identifying specific neuronal dynamics and molecular mechanisms to decrease mortality and reduce national healthcare expenditures associated with neurological disorders.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Research and Development cases More cases from Taiwan

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-01-19.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 90 days
Criteria Met 3 / 3
Evidence Types 6

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in Taiwan All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist